Creo Medical Group PLC (BST:1RC)

Germany flag Germany · Delayed Price · Currency is EUR
0.1480
+0.0040 (2.78%)
At close: Jun 9, 2026
Market Cap69.16M -10.6%
Revenue (ttm)6.88M +50.0%
Net Income6.08M
EPS0.01
Shares Out n/a
PE Ratio11.38
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open0.1440
Previous Close0.1440
Day's Range0.1420 - 0.1480
52-Week Range0.1050 - 0.2100
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateJun 22, 2026

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needl... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2003
Employees 104
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol 1RC

Financial Performance

Financial numbers in GBP Financial Statements

News

Creo Medical Group sees 50% surge in year-on-year revenues

Creo Medical Group reported revenues of £6mn for 2025, up 50% year-on-year, while second-half sales growth accelerated to 58%.

18 days ago - The Armchair Trader